Senior Manager, SEC Reporting & Financial Close

Immix Biopharma, Inc.

Los Angeles (CA)

On-site

USD 180,000 - 240,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Immix Biopharma, Inc. is seeking a senior accounting professional to own monthly closes, SEC reporting, equity administration, and internal controls in a Nasdaq-listed environment.

You will prepare and review 10-Q/10-K, support 8-K and proxy filings, and manage stock-based compensation accounting and equity reporting for the Board. You will work closely with the VP of Finance & Accounting, supporting IFRS-like US GAAP guidance and driving process improvements in a small finance team in a dynamic

Qualifications

  • Bachelor's degree in accounting or related field with CPA status or exams completed.
  • 5–8+ years of progressive accounting experience, including Big 4 experience serving SEC registrants.
  • Hands-on experience preparing/auditing Forms 10-Q and 10-K with strong US GAAP and SOX knowledge.
  • Knowledge of stock-based compensation (ASC 718) and EPS/compliance reporting.
  • Ability to work independently in a small team and communicate clearly in writing.
  • Strong Excel skills and familiarity with SEC/XBRL software and cloud ERP systems.

Responsibilities

  • Lead monthly and quarterly close: journal entries, reconciliations, accruals, flux analysis; manage close calendar to meet 10-Q/10-K deadlines.
  • Prepare or review 10-Q and 10-K, including statements, footnotes, MD&A and XBRL tagging; support 8-K, proxy and related filings.
  • Oversee equity plan administrator and equity ledger; manage stock-based compensation accounting under ASC 718.
  • Coordinate regulatory financial reporting: Nasdaq compliance, government surveys, state/local filings, foreign subsidiary reporting.
  • Interface with external auditors for quarterly reviews and annual audit; maintain SOX controls and remediation.
  • Support future policies for commercial launch accounting and process automation in a small-team setting.

Skills

Big 4 audit
US GAAP knowledge
Excel proficiency
Independent worker
Clear writing

Education

Bachelor's degree in accounting
Active CPA (or exam sections passed)

Tools

SEC filing/XBRL software
Cloud ERP systems
Equity administration platform

Job description

Immix Biopharma, Inc. is seeking a senior accounting professional to own monthly closes, SEC reporting, equity administration, and internal controls in a Nasdaq-listed environment.

You will prepare and review 10-Q/10-K, support 8-K and proxy filings, and manage stock-based compensation accounting and equity reporting for the Board. You will work closely with the VP of Finance & Accounting, supporting IFRS-like US GAAP guidance and driving process improvements in a small finance team in a dynamic

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Manager, Financial Reporting and Accounting
Manager, Financial Reporting and Accounting

Immix Biopharma, Inc. • Los Angeles (CA)

On-site
USD 180,000 - 240,000
SEC Reporting & Equity Accounting Manager
SEC Reporting & Equity Accounting Manager

Neurocrine Biosciences • San Diego (CA)

On-site
USD 120,000 - 180,000
Senior Manager OR Associate Director, Accounting & SEC Reporting (2731125)
Senior Manager OR Associate Director, Accounting & SEC Reporting (2731125)

Hire Point Recruiting • Walkersville (MD)

On-site
USD 100,000 - 130,000
Senior Director, SEC Reporting & SOX Compliance
Senior Director, SEC Reporting & SOX Compliance

Klein Hersh International • Boston (MA)

On-site
USD 180,000 - 240,000
Senior SEC Reporting & Technical Accounting Lead
Senior SEC Reporting & Technical Accounting Lead

Iambic Therapeutics, Inc • San Diego (CA)

Hybrid
USD 170,000 - 210,000
Healthcare
401K matching
Uncapped vacation
+1
SEC Reporting, Sr. Manager
SEC Reporting, Sr. Manager

WatsonBarron Group • Princeton (NJ)

Hybrid
USD 170,000 - 200,000
Strategic SEC Reporting & Equity Accounting Leader
Strategic SEC Reporting & Equity Accounting Leader

Neurocrine Biosciences • San Diego (CA)

Hybrid
USD 120,000 - 164,000
Retirement plan with company match
Paid vacation & holidays
Medical, dental, vision benefits
+1
Senior Director, SEC Reporting & SOX Compliance
Senior Director, SEC Reporting & SOX Compliance

Klein Hersh • Boston (MA)

Hybrid
USD 180,000 - 230,000
Sr. Mgr, SEC Reporting & Technical Accounting
Sr. Mgr, SEC Reporting & Technical Accounting

CorMedix Therapeutics • Chicago (IL)

On-site
USD 150,000 - 190,000
Biotech Accounting Senior Manager - Close, SEC & SOX Lead
Biotech Accounting Senior Manager - Close, SEC & SOX Lead

Foster McKay • Morristown (NJ)

On-site
USD 120,000 - 190,000